国立癌症研究中心东医院

专业领域

放射线治疗

质子线治疗

关键词

放射线治疗

质子治疗

临床试验

化学放射线疗法

放射线生物

现在主要研究课题

关于质子治疗的技术开发

质子线治疗的临床试验

高精度放射线治疗

共同研究可能的领域

放射线治疗・粒子线治疗的临床试验

化学放射线疗法

强度调制放射线治疗

主要所属学会

American Society for Therapeutic Radiology and Oncology

American Society of Clinical Oncology

American Association for Cancer Research

日本癌学会

日本癌治疗学会

日本医学放射线学会

日本放射线肿瘤学会

日本头颈部癌学会

日本食道学会

日本乳癌学会

日本癌分子靶向治疗学会　等

主要论文

1. Hotta K, Kohno R, Nagafuchi K, Yamaguchi H, Tansho R, Takada Y, Akimoto T. Evaluation of monitor unit calculation based on measurement and calculation with a simplified Monte Carlo method for passive beam delivery system in proton beam therapy. J Appl Clin Med Phys, 16:5419, 2015

2. Zenda S, Ishi S, Akimoto T, Arahira S, Motegi A, Tahara M, Hayashi R, Asanuma C. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis. Jpn J Clin Oncol, 45: 433-438, 2015

3. Tahara M, Kiyota N, Mizusawa J, Nakamura K, Hayashi R, Akimoto T, Hasegawa Y, Iwae S, Monden N, Matsuura K, Fujii H, Onozawa Y, Homma A, Kubota A, Fukuda H, Fujii M. Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706). Cancer Sci, 106:726-733, 2015

4. Mizowaki T, Aoki M, Nakamura K, Yorozu A, Kokubo M, Karasawa K, Kozuka T, Nakajima N, Sasai K, Akimoto T. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study. J Radiat Res, 56:750-756, 2015

5. Hashimoto Y, Akimoto T, Iizuka J, Tanabe K, Mitsuhashi N. Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer. Jpn J Clin Oncol, 45:81-87, 2015

6. Zenda S, Kawashima M, Arahira S, Kohno R, Nishio T, Tahara M, Hayashi R, Akimoto T. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up. Int J Clin Oncol, 20:447-454, 2015

7. Maebayashi T, Ishikawa H, Yorozu A, Yoshida D, Katoh H, Nemoto K, Ishihara S, Takemoto S, Ishibashi N, Tokumaru S, Akimoto T on behalf of Working Subgroup of Urological Cancers in Japanese Radiation Oncology Study Group. Patterns of practice in the radiation therapy for bladder cancer: survey of the Japanese Radiation Oncology Study Group (JROSG). Jpn J Clin Oncol, 44:1109-1115, 2014

8. Shinozaki T, Hayashi R Miyazaki M, Tomioka T, Zenda S, Tahara T, Akimoto T. Gastrostomy dependence in head and neck carcinoma patient receiving post-operative therapy. Jpn J Clin Oncol, 44:1058-1062, 2014

9. Motegi A, Kawashima M, Arahira S, Zenda S, Toshima M, Onozawa M, Hayashi R, Akimoto T. Accelerated radiotherapy for T1 to T2 glottic cancer. Head Neck, 37:579-584, 2015

10. Motegi K, Kohno R, Ueda T, Shibuya T, Ariji T, Kawashima M, Akimoto T. Evaluating positional accuracy using megavoltage cone-beam computed tomography for IMRT with head-and-neck cancer. J Radiat Res, 55:568-574, 2014

11. Aoki M, Mizowaki T, Akimoto T, Nakamura K, Ejima Y, Jingu K, Tamai Y, Nakajima N, Takemoto S, Kokubo M, Katoh H. Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG. J Radiat Res, 55: 533-540, 2014

12. Tansho R, Takada Y, Kohno R, Hotta K, Hara Y, Mizutani S, Akimoto T. Experimental verification of dose calculation using the simplified Monte Carlo method with an improved initial beam model for a beam-wobbling system. Phys Med Biol, 58:6047-6064, 2013

13. Kawashima M, Ariji T, Kameoka S, Ueda T, Kohno R, Nishio T, Arahira S, Motegi A, Zenda S, Akimoto T, Tahara M, Hayashi R. Locoregional control after intensity-modulated radiotherapy for nasopharyngeal carcinoma with an anatomy-based target definition. Jpn J Clin Oncol, 43:1218-1225, 2013

14. Zenda S, Nakagami Y, Toshima M, Arahira S, Kawashima M, Matsumoto Y, Kinoshita H, Satake M, Akimoto T. Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases. Int J Clin Oncol, 19:739-743, 2014

15. Matsubara K, Kohno R, Nishioka S, Shibuya T, Ariji T, Akimoto T, Saitoh H. Experimental evaluation of actual delivered dose using mega-voltage cone-beam CT and direct point dose measurement. Med Dosim, 38:153-159, 2013

16. Kiyozuka M, Akimoto T, Fukutome M, Motegi A, Mitsuhashi N. Radiation-induced dimer formation of EGFR: implications for the radiosensitizing effect of cetuximab. Anticancer Res, 33:4337-4346, 2013

17. Okano S, Yoshino T, Fujii M, Onozawa Y, Kodaira T, Fujii H, Akimoto T, Ishikura S, Oguchi M, Zenda S, de Blas B, Tahara M. Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol, 43:476-482, 2013

18. Sugimoto M, Gotohda N, Kato Y, Takahashi S, Kinoshita T, Shibasaki H, Kojima M, Ochiai A, Zenda S, Akimoto T, Konishi M. Pancreatic resection for metastatic melanoma originating from the nasal cavity: a case report and literature review. Anticancer Res, 33:567-573, 2013

19. Nakamura K, Akimoto T, Mizowaki T, Hatano K, Kodaira T, Nakamura N, Kozuka T, Shikama N, Kagami Y. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan. Jpn J Clin Oncol, 42:53-57, 2012

20. Hojo H, Zenda S, Akimoto T, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Sasai K. Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies. J Radiat Res, 53:704-709, 2012

21. Okamoto M, Ishikawa H, Ebara T, Kato H, Tamaki T, Akimoto T, Ito K, Miyakubo M, Yamamoto T, Suzuki K, Takahashi T, Nakano T. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate. Int J Radiat Oncol Biol Phys, 82:211-217, 2012

22. Zenda S, Matsuura K, Tachibana H, Homma A, Kirita T, Monden N, Iwae S, Ota Y, Akimoto T, Otsuru H, Tahara M, Kato K, Asai M. Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiother Oncol, 101:410-414, 2011